Zurcher Kantonalbank (Zurich Cantonalbank) - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$709,532
+0.1%
44,709
+19.0%
0.00%0.0%
Q2 2023$708,757
+513.0%
37,560
+24.8%
0.00%
+200.0%
Q1 2023$115,615
-30.0%
30,108
-9.6%
0.00%0.0%
Q4 2022$165,237
+2.0%
33,314
-1.5%
0.00%0.0%
Q3 2022$162,000
+47.3%
33,832
+37.8%
0.00%0.0%
Q2 2022$110,000
-34.9%
24,545
-30.7%
0.00%0.0%
Q1 2022$169,000
-27.8%
35,407
+12.0%
0.00%0.0%
Q4 2021$234,000
+27.9%
31,600
-1.9%
0.00%0.0%
Q3 2021$183,000
-13.7%
32,218
+0.2%
0.00%0.0%
Q2 2021$212,000
-17.2%
32,144
+1.6%
0.00%
-50.0%
Q1 2021$256,000
+116.9%
31,633
+72.6%
0.00%
+100.0%
Q4 2020$118,000
+78.8%
18,3260.0%0.00%
Q3 2020$66,000
-21.4%
18,3260.0%0.00%
-100.0%
Q2 2020$84,000
+86.7%
18,326
+37.9%
0.00%
Q1 2020$45,000
+7.1%
13,287
+61.1%
0.00%
Q4 2019$42,000
+110.0%
8,2460.0%0.00%
Q3 2019$20,000
+11.1%
8,2460.0%0.00%
Q2 2019$18,000
-18.2%
8,2460.0%0.00%
Q1 2019$22,000
-60.0%
8,246
-28.4%
0.00%
-100.0%
Q4 2018$55,000
-49.5%
11,5210.0%0.00%0.0%
Q3 2018$109,000
+18.5%
11,521
+22.0%
0.00%0.0%
Q2 2018$92,000
-21.4%
9,446
-15.2%
0.00%0.0%
Q1 2018$117,000
+387.5%
11,144
+198.5%
0.00%
Q4 2017$24,000
-17.2%
3,7330.0%0.00%
Q3 2017$29,000
+107.1%
3,733
+87.1%
0.00%
Q2 2017$14,000
+75.0%
1,9950.0%0.00%
Q1 2017$8,000
+100.0%
1,9950.0%0.00%
Q4 2016$4,000
-20.0%
1,9950.0%0.00%
Q3 2016$5,000
-16.7%
1,9950.0%0.00%
Q2 2016$6,000
-64.7%
1,9950.0%0.00%
Q1 2016$17,000
-37.0%
1,9950.0%0.00%
Q4 2015$27,000
+200.0%
1,995
+109.1%
0.00%
Q3 2015$9,000
-99.3%
954
-98.9%
0.00%
-100.0%
Q4 2013$1,320,000
-59.2%
90,000
-52.6%
0.04%
-61.6%
Q3 2013$3,234,000
+549.4%
190,000
+533.3%
0.11%
+558.8%
Q2 2013$498,000
-72.0%
30,000
-72.9%
0.02%
-72.6%
Q1 2013$1,776,000
-7.2%
110,603
-26.3%
0.06%
-17.3%
Q4 2012$1,913,000
+39.8%
150,000
+60.1%
0.08%
+36.4%
Q3 2012$1,368,000
+243.7%
93,700
+295.4%
0.06%
+205.6%
Q2 2012$398,000
+16.7%
23,7000.0%0.02%
+20.0%
Q1 2012$341,00023,7000.02%
Other shareholders
IMMUNOGEN INC shareholders Q3 2023
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders